International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Issue 2 (February 2020)
- Record Type:
- Journal Article
- Title:
- International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Issue 2 (February 2020)
- Main Title:
- International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
- Authors:
- Coens, Corneel
Pe, Madeline
Dueck, Amylou C
Sloan, Jeff
Basch, Ethan
Calvert, Melanie
Campbell, Alicyn
Cleeland, Charles
Cocks, Kim
Collette, Laurence
Devlin, Nancy
Dorme, Lien
Flechtner, Hans-Henning
Gotay, Carolyn
Griebsch, Ingolf
Groenvold, Mogens
King, Madeleine
Kluetz, Paul G
Koller, Michael
Malone, Daniel C
Martinelli, Francesca
Mitchell, Sandra A
Musoro, Jammbe Z
O'Connor, Daniel
Oliver, Kathy
Piault-Louis, Elisabeth
Piccart, Martine
Quinten, Chantal
Reijneveld, Jaap C
Schürmann, Christoph
Smith, Ashley Wilder
Soltys, Katherine M
Taphoorn, Martin J B
Velikova, Galina
Bottomley, Andrew
… (more) - Abstract:
- Summary: Patient-reported outcomes (PROs), such as symptoms, function, and other health-related quality-of-life aspects, are increasingly evaluated in cancer randomised controlled trials (RCTs) to provide information about treatment risks, benefits, and tolerability. However, expert opinion and critical review of the literature showed no consensus on optimal methods of PRO analysis in cancer RCTs, hindering interpretation of results. The Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium was formed to establish PRO analysis recommendations. Four issues were prioritised: developing a taxonomy of research objectives that can be matched with appropriate statistical methods, identifying appropriate statistical methods for PRO analysis, standardising statistical terminology related to missing data, and determining appropriate ways to manage missing data. This Policy Review presents recommendations for PRO analysis developed through critical literature reviews and a structured collaborative process with diverse international stakeholders, which provides a foundation for endorsement; ongoing developments of these recommendations are also discussed.
- Is Part Of:
- Lancet oncology. Volume 21:Issue 2(2020)
- Journal:
- Lancet oncology
- Issue:
- Volume 21:Issue 2(2020)
- Issue Display:
- Volume 21, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 21
- Issue:
- 2
- Issue Sort Value:
- 2020-0021-0002-0000
- Page Start:
- e83
- Page End:
- e96
- Publication Date:
- 2020-02
- Subjects:
- Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1470-2045(19)30790-9 ↗
- Languages:
- English
- ISSNs:
- 1470-2045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23164.xml